MT-301

N/A

Report date: 2025/12/26 17:48:39

Base Information

Drug NameMT-301
Drug Alias NameGPC3-FcA LNP(Myeloid Therapeutics)MT-301
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionGlypican-3 inhibitorsWnt signalling pathway inhibitors
TargetsGlypican-3
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyeloid Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMyeloid Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A